CINCINNATI--(BUSINESS WIRE)--LIB Therapeutics Inc. (LIB), a late-stage biopharmaceutical company developing subcutaneous and oral PCSK9 inhibitor therapies for patients at very high and high-risk of ...
Privately-held drug developer LIB Therapeutics has claimed FDA approval for a new once-monthly PCSK9 inhibitor – Lerochol – that can be used to reduce cholesterol levels. The injectable product has ...
LIB Therapeutics has scored an FDA approval for its cholesterol-lowering, third-generation PCSK9 inhibitor, lerodalcibep-liga. The injected treatment, which will carry the commercial name Lerochol, is ...
Lib Dem leader Martin Smith (centre) at the local election count The Liberal Democrats have stepped aside from the leadership contest at Sheffield Council, saying they will instead be a "principled ...
LIBerate-HoFH study was part of a global registration-enabling Phase 3 program of > 2,900 patients Biologics license application for lerodalcibep submitted to FDA in December 2024 ...
Labour, the Tories and the Liberal Democrats all came out with their manifestos this week. As you’d expect, each party is keen to prove that theirs is the right vision for Britain at this time of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results